End stage renal disease
Conditions
Interventions
None listed
Sponsors
Shizuoka General Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: The present sturdy targets at end stage renal disease females, who were receiving hemodialysis therapy or peritoneal dialysis therapy in Japan. (1) They should be in ages between 15 to 44 during a period between 2012/1/1 and 2016/12/31. (2) They or their proxy should provide informed consent based upon their own free will.
Exclusion criteria
Exclusion criteria: (1) Patients who moved to other dialysis centers at reply of questionnaires are excluded. (2) Patients who were no longer receiving dialysis therapy due to recovery of renal function or renal transplantation at reply of questionnaires are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of pregnancy among end stage renal disease patients at ages between 15 to 44, who were receiving dialysis therapy during a period between 2012/1/1 and 2016/12/31. Incidence of pregnancy will be determined by questionnaires collected from treating physicians in dialysis centers. | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Incidence of pregnancy among end stage renal disease patients at ages between 15 to 44, who were receiving dialysis therapy during a period between 2012/1/1 and 2016/12/31. It will be determined by questionnaires collected from eligible female patients. (2) Incidence of live-born neonates (who survived more than for 28 days) delivered by end stage renal disease patients at ages between 15 to 44. Incidence of spontaneous abortion, elective abortion, stillborn baby and neonatal death are also studied. | — |
Countries
Japan
Contacts
Public ContactHiroko Hirano
Shizuoka General Hospital Department of Nephrology
Outcome results
None listed